5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
SELL | SELL | SELL | SELL | SELL |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 8.29▼ | 8.34▼ | 8.33▼ | 8.72▼ | 8.75▼ |
MA10 | 8.31▼ | 8.33▼ | 8.36▼ | 8.84▼ | 9.39▼ |
MA20 | 8.35▼ | 8.35▼ | 8.51▼ | 8.87▼ | 11.18▼ |
MA50 | 8.34▼ | 8.64▼ | 8.85▼ | 9.83▼ | 10.66▼ |
MA100 | 8.35▼ | 8.85▼ | 8.83▼ | 11.36▼ | 10.37▼ |
MA200 | 8.55▼ | 8.84▼ | 9.04▼ | 11.36▼ | 8.09▲ |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | -0.011▼ | 0.015▲ | -0.004▼ | 0.028▲ | -0.471▼ |
RSI | 35.594▼ | 36.824▼ | 32.645▼ | 33.039▼ | 37.854▼ |
STOCH | 13.030▼ | 50.744 | 27.560 | 59.524 | 12.259▼ |
WILL %R | -92.308▼ | -95.238▼ | -97.619▼ | -67.514 | -93.976▼ |
CCI | -145.608▼ | -120.952▼ | -111.468▼ | -191.531▼ | -87.458 |
Wednesday, August 13, 2025 05:35 AM
Q2 2025 Earnings Call Transcript August 12, 2025 NeuroPace, Inc. misses on earnings expectations. Reported EPS is $-0.26 EPS, expectations were $-0.24. Operator: Ladies and gentlemen, greetings, and ...
|
Wednesday, August 13, 2025 12:36 AM
NeuroPace Inc (NPCE) reports a 22% revenue growth and raises full-year guidance amidst promising trial data and strategic financial moves.
|
Tuesday, August 12, 2025 06:51 PM
NeuroPace (NPCE) achieves record Q2 2025 revenue with 22% growth, raises guidance, advances AI innovations & regulatory progress.
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
19/08/25 | 8.32 | 8.50 | 8.20 | 8.25 | 216,565 |
18/08/25 | 8.63 | 8.67 | 8.31 | 8.42 | 243,081 |
15/08/25 | 9.00 | 9.22 | 8.51 | 8.56 | 285,472 |
14/08/25 | 9.32 | 9.32 | 8.72 | 9.03 | 180,283 |
13/08/25 | 8.95 | 9.6788 | 7.5625 | 9.32 | 416,737 |
12/08/25 | 8.91 | 9.29 | 8.795 | 9.13 | 244,823 |
11/08/25 | 8.98 | 9.21 | 8.87 | 8.89 | 116,795 |
08/08/25 | 8.99 | 9.09 | 8.6815 | 8.98 | 137,059 |
07/08/25 | 8.96 | 9.1173 | 8.82 | 8.92 | 152,021 |
06/08/25 | 8.70 | 8.92 | 8.635 | 8.89 | 239,253 |
|
|
||||
|
|
||||
|
|